PRMA Insights: The Roadmap to Pricing and Reimbursement Success
Welcome
PRMA Insights is a unique series of strategic publications addressing the critical global pricing, reimbursement and market access challenges and opportunities by disease area. Each comprehensive resource critically reviews all the major health technology assessment (HTA) and pricing and reimbursement decisions by disease area in the US, UK, France, Germany, Spain, Italy and Japan, and unravels the complexity around pricing and reimbursement. It delivers actionable insights to apply to your clinical development program in order to develop a robust evidence-based payer-value proposition.
Written by a team of industry-experienced individuals, each resource provides comprehensive secondary research, experience-based insight, and validation by payers and key opinion leaders (KOLs) across markets. PRMA Insights helps to minimise the market access risk and to maximize the market opportunity for commercial success.
- Design a roadmap for your product to achieve successful global market access
- Ensure your strategic plan reflects current and future market access realities
- Develop pricing and reimbursement and health outcomes strategies
- Understand the pricing and reimbursement implications for new products in the US, UK, France, Germany, Spain, Italy and Japan
- Design your clinical development program to ensure relevant health economic and patient-reported outcome endpoints are captured
- Build forecast models that reflect market access realities
- Inform candidate selection and R&D portfolio prioritization
- Assess in-licensing opportunities and identify market access levers to negotiate favourable deal terms
- Develop an evidence-based value proposition in order to maximise deal value for your out-licensed product.
